Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT03050814
What this trial is testing

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Who this might be right for
Colorectal TumorsColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00721916
What this trial is testing

Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 107
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT00506571
What this trial is testing

Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorecal NeoplasmsSecondary
National Cancer Center, Korea 42
Testing effectiveness (Phase 2)Study completedNCT02305758
What this trial is testing

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Untreated Metastatic Colorectal Cancer
AbbVie 130
Testing effectiveness (Phase 2)Study completedNCT02743221
What this trial is testing

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 154
Testing effectiveness (Phase 2)Study completedNCT00940303
What this trial is testing

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 97
Large-scale testing (Phase 3)Study completedNCT00294359
What this trial is testing

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group 333
Testing effectiveness (Phase 2)UnknownNCT00524706
What this trial is testing

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shizuoka Cancer Center 42
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT00040391
What this trial is testing

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDiarrhea
Celgene Corporation
Large-scale testing (Phase 3)Study completedNCT00384176
What this trial is testing

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Who this might be right for
Colorectal Cancer
AstraZeneca 1,814
Testing effectiveness (Phase 2)Ended earlyNCT00449163
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Miami 25
Testing effectiveness (Phase 2)Study completedNCT03174405
What this trial is testing

Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 43
Testing effectiveness (Phase 2)Study completedNCT01110941
What this trial is testing

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China

Who this might be right for
Colorectal Cancer
Shen Lin 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03635021
What this trial is testing

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 419
Next Page